The data revealed that β-catenin or TCF4 knockdown did not affect the expression of NRF1. These data indicate that the β-catenin/TCF4-NRF3 axis is present in other tissue-derived cancer cells that harbor mutations in the Wnt pathway. Here, NFE2L3 is linked to cancer.